Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Public Health (3)
- Alternative and Complementary Medicine (2)
- Diseases (2)
- Emergency Medicine (2)
- Life Sciences (2)
-
- Medical Sciences (2)
- Medical Specialties (2)
- Mental and Social Health (2)
- Other Chemicals and Drugs (2)
- Other Medical Sciences (2)
- Other Public Health (2)
- Pharmaceutical Preparations (2)
- Pharmacy and Pharmaceutical Sciences (2)
- Substance Abuse and Addiction (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Anatomy (1)
- Anesthesia and Analgesia (1)
- Behavioral Neurobiology (1)
- Biomedical and Dental Materials (1)
- Chemical Actions and Uses (1)
- Chemical and Pharmacologic Phenomena (1)
- Chemistry (1)
- Clinical Epidemiology (1)
- Clinical and Medical Social Work (1)
- Cognitive Behavioral Therapy (1)
- Community Health (1)
- Community Health and Preventive Medicine (1)
- Institution
- Keyword
- Publication
- File Type
Articles 1 - 4 of 4
Full-Text Articles in Complex Mixtures
Development Of Metal-Organic Framework-Based Formulation For Cancer Therapeutics, Kaitlyn D. Ybanez, Rahul Tiwari, Joel De Los Santos, Tarun Minocha, Bianca Jimenez, Subhash Chauhan, Murali Yallapu
Development Of Metal-Organic Framework-Based Formulation For Cancer Therapeutics, Kaitlyn D. Ybanez, Rahul Tiwari, Joel De Los Santos, Tarun Minocha, Bianca Jimenez, Subhash Chauhan, Murali Yallapu
Research Colloquium
Background: Novel hydrogel-based drug delivery systems integrating 𝛾-cyclodextrin metal-organic frameworks (𝛾-CD-MOFs) have recently been developed to overcome the hydrophobicity and poor bioavailability of certain chemotherapeutic drugs. Thermosensitive Pluronic F-127 hydrogels can deliver 𝛾-CD-MOFs to target sites, promoting sustained and regulated drug release, especially for mucosal adhesion scenarios as warranted in cervical cancer. This study presents the development of a formulation that encapsulates curcumin, a model anticancer agent, into a Pluronic F-127 Hydrogel + 𝛾-CD-MOFs to enhance dispersion and enable sitespecific gelation at physiological temperatures (37°C).
Methods: Curcumin-loaded 𝛾-CD-MOFs were synthesized by dissolving 𝛾-CD (1.0 mmol, 1.30 g) and KOH …
Release The Kratom: Post-Acute Withdrawal Syndrome In A 70 Year Old Male, Nardin El-Shammaa, Kyle Street, Narsimha Pinninti
Release The Kratom: Post-Acute Withdrawal Syndrome In A 70 Year Old Male, Nardin El-Shammaa, Kyle Street, Narsimha Pinninti
Rowan-Virtua Research Day
Centuries in Eastern medicine.. Kratom has been commonly used for chronic pain and opiate withdrawal symptoms with first reported cases in the United States in the early 2000s. It is a plant that consists of psychoactive alkaloids that target opioid receptors with different affinity. Effects from Kratom are dose-dependent, at lower doses, it acts as a stimulant, while at higher doses produces analgesia and euphoria. Although Kratom is legal and easily accessible over the counter, there have been increasing reports of potential for addiction and toxicity. Cessation of Kratom can result in withdrawal symptoms similar to opiate withdrawal. Here we …
A Quantitative Analysis Of The Efficacy Of Various Essential Oils Against The Sars Cov-2 Virus, Elizabeth Wagstaff, Chandrelyn Kraczek, Jack Brandon Lopez
A Quantitative Analysis Of The Efficacy Of Various Essential Oils Against The Sars Cov-2 Virus, Elizabeth Wagstaff, Chandrelyn Kraczek, Jack Brandon Lopez
Annual Research Symposium
A poster presentation and abstract for the Roseman Symposium. The project focuses on testing 3 essential oil blends and two disinfectants containing an essential oil blend against SARS CoV-2 in response to the COVID-19 pandemic. The project procedure involves plaque assays, disinfection, and neutralization techniques.
Opioid Use Disorder: The Timeline For Medication Assisted Therapy, Alexander Cristofori
Opioid Use Disorder: The Timeline For Medication Assisted Therapy, Alexander Cristofori
Capstone Showcase
Opioid Use Disorder is patterns of opioid use leading to withdrawal, giving up important life events in order to use opioids, and excessive time spent using opioids, to name a few diagnostic criteria. The clinical progression of the disorder involves periods of acute exacerbation and remission that are cyclic in nature. Treatment is most effective when it includes both pharmacological and psychosocial modalities, referred to as medication assisted therapy (MAT). Three drugs used commonly in MAT-based treatment for OUD from oldest to newest include Methadone, Buprenorphine-naloxone, and Naltrexone. Treatment program models that prioritize total abstinence from the addictive substance attached …